These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 139265

  • 1. Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidine).
    Krook G.
    Contact Dermatitis; 1975 Dec; 1(6):385-6. PubMed ID: 139265
    [No Abstract] [Full Text] [Related]

  • 2. Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidin).
    Krook G.
    Contact Dermatitis; 1975 Aug; 1(4):262. PubMed ID: 139243
    [No Abstract] [Full Text] [Related]

  • 3. Drug reaction from oxyphenbutazone.
    Valsecchi R, Tornaghi A, Falgheri G, Rossi A, Cainelli T.
    Contact Dermatitis; 1983 Sep; 9(5):419. PubMed ID: 6226482
    [No Abstract] [Full Text] [Related]

  • 4. [Vasculitis allergica cutis caused by phenylbutazone].
    Paschoud JM.
    Dermatologica; 1966 Sep; 133(1):76-86. PubMed ID: 4224583
    [No Abstract] [Full Text] [Related]

  • 5. Contact sensitivity to phenylbutazone (Butazolidine) cream.
    Nayar M, Ng SK.
    Contact Dermatitis; 1991 Oct; 25(4):263-4. PubMed ID: 1839274
    [No Abstract] [Full Text] [Related]

  • 6. Primary fibrositis and its treatment with the pyrazolone derivatives, butazolidin and tandearil.
    Klinefelter HF.
    Johns Hopkins Med J; 1972 May; 130(5):300-7. PubMed ID: 4259693
    [No Abstract] [Full Text] [Related]

  • 7. Immunological evidence of two forms of allergy to pyrazolone drugs.
    Littlejohns DW, Assem ES, Kennedy CT.
    Rheumatol Rehabil; 1973 May; 12(2):57-61. PubMed ID: 4126302
    [No Abstract] [Full Text] [Related]

  • 8. [A CONTRIBUTION TO THE ANTIPHLOGISTIC EFFECT OF TANDERIL, BUTAZOLIDINE AND DELTA-BUTAZOLIDINE].
    HIEMEYER V.
    Med Klin; 1963 Dec 20; 58():2095-7. PubMed ID: 14115095
    [No Abstract] [Full Text] [Related]

  • 9. Drug reactions. XII. Cutaneous reactions to anti-rheumatic drugs.
    Almeyda J, Baker H.
    Br J Dermatol; 1970 Dec 20; 83(6):707-11. PubMed ID: 4250591
    [No Abstract] [Full Text] [Related]

  • 10. Withdrawal of oxyphenbutazone: what about phenylbutazone?
    Biron P.
    CMAJ; 1986 May 15; 134(10):1119-20. PubMed ID: 3697857
    [No Abstract] [Full Text] [Related]

  • 11. Phenylbutazone, oxyphenbutazone labeling revised.
    FDA Drug Bull; 1984 Dec 15; 14(3):23-4. PubMed ID: 6526172
    [No Abstract] [Full Text] [Related]

  • 12. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone.
    Inman WH.
    Br Med J; 1977 Jun 11; 1(6075):1500-5. PubMed ID: 871632
    [Abstract] [Full Text] [Related]

  • 13. Contact sensitivity to oxyphenbutazone.
    Valsecchi R, Serra M, Foiadelli L, Cainelli T.
    Contact Dermatitis; 1981 May 11; 7(3):157. PubMed ID: 7273732
    [No Abstract] [Full Text] [Related]

  • 14. [Frequency of side effects of pyrazoles].
    Villiaumey J, Larget-Piet B.
    Therapie; 1976 May 11; 31(3):299-311. PubMed ID: 136763
    [No Abstract] [Full Text] [Related]

  • 15. Letter: Fixed skin eruption caused by oxyphenbutazone with cross-reactivity to phenylbutazone.
    Pandhi RK, Dedi TR.
    Arch Dermatol; 1975 Jan 11; 111(1):131. PubMed ID: 1119818
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phenylbutazone and oxyphenbutazone: time to call a halt.
    Drug Ther Bull; 1984 Jan 27; 22(2):5-6. PubMed ID: 6692755
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fixed drug eruption to oxyphenbutazone and phenylbutazone.
    Nayyar KC, Pasricha JS.
    Dermatologica; 1972 Jan 27; 144(4):214-6. PubMed ID: 5076722
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.